Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

Class III antiarrhythmic presented by Japanese academics

April 26, 1996

Kanebo reveals new Na+/Ca2+ exchange inhibitor

April 26, 1996

FR-168888 shows myocardial protective effects in animals

April 26, 1996

Banyu's BR-1022 for angina

April 26, 1996

CP-060S suppresses myocardial cell calcium overload

April 26, 1996

Novel vasodilator MCC-134 reported by Mitsubishi Chemical

April 26, 1996

PC-286 lowers blood pressure in rats

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...